Midodrine
- Generic Name
- Midodrine
- Brand Names
- Proamatine
- Drug Type
- Small Molecule
- Chemical Formula
- C12H18N2O4
- CAS Number
- 42794-76-3
- Unique Ingredient Identifier
- 6YE7PBM15H
- Background
An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension.
- Indication
For the treatment of symptomatic orthostatic hypotension (OH).
- Associated Conditions
- Symptomatic Orthostatic Hypotension
- Associated Therapies
- -
Treatment of Orthostatic Intolerance
Phase 1
Active, not recruiting
- Conditions
- Interventions
- Drug: AtomoxetineDrug: AcetazolamideDietary Supplement: MelatoninOther: NO DrugDrug: Isosorbide DinitrateRadiation: PlaceboDevice: Breathing DeviceOther: Drinking WaterProcedure: IV SalineDevice: Abdominal binderDrug: IndomethacinDrug: MidodrineDrug: MecamylamineDrug: ClonidineDrug: EntacaponeDrug: memantineDrug: ModafinilDrug: OctreotideDrug: SertralineDrug: Atomoxetine & PropranololDrug: Entacapone & PropranololDrug: PropranololDrug: Modafinil & Propranolol
- First Posted Date
- 2005-12-06
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Satish R. Raj
- Target Recruit Count
- 150
- Registration Number
- NCT00262470
- Locations
- 🇺🇸
Vanderbilt University Autonomic Dysfunction Center, Nashville, Tennessee, United States
Treatment of Orthostatic Hypotension in Autonomic Failure
Phase 1
Completed
- Conditions
- Interventions
- Drug: AtomoxetineDrug: placeboDrug: AcarboseDevice: inflatable abdominal binder (sham)Drug: Pyridostigmine BromideDrug: YohimbineDrug: Midodrine HClDrug: ModafinilDrug: OctreotideOther: water intakeDrug: Diphenhydramine HydrochlorideDrug: Ranitidine HCLDrug: TranylcypromineDrug: Ergotamine/ CaffeineDrug: CelecoxibDrug: PseudoephedrineDrug: MethylphenidateDrug: IndomethacinDrug: IbuprofenDrug: Oxymetazoline 0.05% nasal solutionDietary Supplement: BovrilDrug: AcetazolamideDrug: Rivastigmine tartrateDrug: Carbidopa/levodopaDevice: Inflatable abdominal binder
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 389
- Registration Number
- NCT00223691
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
- First Posted Date
- 2005-04-15
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 29
- Registration Number
- NCT00108355
- Locations
- 🇺🇸
VA Connecticut Health Care System (West Haven), West Haven, Connecticut, United States
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 300
- Registration Number
- NCT00004268
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
Not Applicable
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Registration Number
- NCT00004479
- Locations
- 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath